Towards a framework: Biotechnology Statistics RIS 04/7-8/2004. by Brigitte van Beuzekom

Transcription

1 1

2 Towards a framework: Biotechnology Statistics RIS 04/7-8/2004 by Brigitte van Beuzekom brigitte.vanbeuzekom@oecd.org

3 In 1999 the WPB asks NESTI to undertake a feasibility study of collecting internationally comparable biotech In March 2000 the OECD held its first ad hoc Biotech Statistics meeting WPB = working party on biotech NESTI = national experts of S&T indicators 3

4 nventory of data

5 To prepare the inventory the OECD sent out a mini-survey to its Members asking them whether they collected biotech and also what definition they were using 5

6 Summary of national existing stats very little official data available most countries had future plans of including question in national surveys there are different definitions of biotech in use 6

7 Summary of national existing stats studies use other sources to give indication of biotech industry 7

8 What are these other sources? Consulting firms (E&Y etc) Patent data Citations Budget data 8

9 What are these other sources? (continued) Venture capital Trade data Data on Alliances Biotech Associations 9

10 What s the problem with different sources? 10

11 Biotech in Canada in 1997 (Canadian $) E&Y Contact Canada StatsCan Companies Employees Sales $ 979 M $4.1 B $1.13 B R&D $403 M $1.73 B $585 M Source: BIOTECanada, Canadian Biotechnology 98,

12 This is just one example of how different definitions can lead to different answers. This is a problem when trying to compare data internationally. 12

13 Results of the first ad hoc biotech stats meeting: Inventory [STI Working paper 2000/6] There was an interest in seeing what type of data was available make a compendium Work on establishing a definition of biotech which could be used across OECD countries 13

14 A Time line of OECD efforts to collect Biotechnology Statistics Definitions: single & list Inventory of data Compendium Biotech Stats

15 Statistical definition of biotechnology Background: two types of definitions were needed -- a single definition and a list based definition depending on the purpose of data collection A provisional single definition and a list based definition were adopted 15

16 The first metrics of publicly available biotechnology brought together in an OECD working paper [STI Working paper 2001/6] 16

17 A Time line of OECD efforts to collect Biotechnology Statistics User needs Definitions: single & list Model Surveys: R&D and Use Inventory of data Compendium Biotech Stats Review of provisional definition

18 Work for the third meeting: A review/ testing by experts in Member countries of the provisional definition Work to develop a common methodology for measurement in 4 steps: 1. Developing a model methodology for use in R&D surveys; 2. Developing a model methodology for use in special surveys of biotechnology; 18

19 Work for the third meeting: 3.Undertake a review of the adequacy of classifications for use in measuring biotechnology; 4. Developing proposals on how to link work on measuring biotechnology to other methodological manuals; (Frascati and Oslo Manuals) 19

20 Work for the third meeting: And also start looking at user needs or making a list of indicators needed to best inform policy actions linking biotech policy to indicators. 20

21 A Time line of OECD efforts to collect Biotechnology Statistics Inventory of data Definitions: single & list Compendium Biotech Stats User needs Model Surveys: R&D and Use Review of provisional definition Review Draft Framework Compile pilot tests of R&D surveys Classify by Patent Classes Review list & single definition

22 A Time line of OECD efforts to collect Biotechnology Statistics Inventory of data Definitions: single & list Compendium Biotech Stats User needs Model Surveys: R&D and Use Review of provisional definition Review Draft Framework Compile pilot tests of R&D surveys Classify by Patent Classes Review list & single definition Preliminary Analysis of Impacts 2nd R&D Survey data Compile Use Survey data Finalize Draft Framework

23 The statistical framework is divided into the following chapters: Basic definitions to be used for statistical purposes; User needs: policy issues to be addressed and indicators to address the above; Collection guidelines on how to best compile the above model survey; Set of classifications that can be used; Links to other statistical frameworks. 23

24 The Fifth Ad hoc Biotechnology Statistics meeting will be held May in Paris. (Agenda hand-outs) Followed by a workshop on the Economic Impacts of biotechnology May 26 (hand-out) And the Working Party on Biotechnology May

25 The OECD is very interested in including non-member countries in our work on biotechnology. If you, or a colleague, are interested in participating in our work please do not hesitate to contact me. brigitte.vanbeuzekom@oecd.org 25